Efficacy And Safety Of Lenalidomide, Rituximab Combined With Second-Line Chemotherapy (R-2-Chemo) In Patients With Relapsed/Refractory Diffuse Large-B Cell LymphomaFei Xiao,Honghui Huang,Yanni Hua,Yi Fang,Minyue Zhang,Jian HouBLOOD(2020)引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要